Nanna Nyholm
Ballerup, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Cost per responder of biologic drugs used in the treatment of moderate-to-severe plaque psoriasis in France and Germany.
Journal: Current medical research and opinion
Published: May 19, 2023
The Cost-Effectiveness of Anti-IL17 Biologic Therapies for Moderate-to-Severe Plaque Psoriasis Treatment in Italy and Germany: A Sequential Treatment Analysis.
Journal: ClinicoEconomics and outcomes research : CEOR
Published: April 20, 2023
Impact of fixed-dose combination Cal/BD foam on the work productivity of patients with psoriasis: results from the 52-week randomized, double-blind, PSO-LONG trial.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: October 12, 2021
Quality of life and patient-perceived symptoms in patients with psoriasis undergoing proactive or reactive management with the fixed-dose combination Cal/BD foam: A post-hoc analysis of PSO-LONG.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: June 25, 2021
Clinical, patient and estimated cost benefits of proactive management versus reactive management with calcipotriol/betamethasone dipropionate foam for the treatment of plaque psoriasis in Finland.
Journal: The Journal of dermatological treatment
Published: June 16, 2021
The Effect on BSA of Proactive Management versus Reactive Management of Psoriasis With Fixed-Dose Cal/BD Foam in the PSO-LONG Study.
Journal: Journal of drugs in dermatology : JDD
Published: May 03, 2021
Reply: Re: Wu JJ, Hansen JB, Patel DS, et al. Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis. J Med Econ. 2020;23(6):641-649.
Journal: Journal of medical economics
Published: October 12, 2020
Effectiveness comparison and incremental cost-per-responder analysis of calcipotriene 0.005%/betamethasone dipropionate 0.064% foam vs. halobetasol 0.01%/tazarotene 0.045% lotion for plaque psoriasis: a matching-adjusted indirect comparative analysis.
Journal: Journal of medical economics
Published: January 28, 2020
A three-year national follow-up study on the development of community-level cancer rehabilitation in Denmark.
Journal: Scandinavian journal of public health
Published: December 08, 2017
Diversity in cancer care: exploring social categories in encounters between healthcare professionals and breast cancer patients.
Journal: Scandinavian journal of caring sciences
Published: July 12, 2017
Showing 1-11 of 11
Last Updated: 09/26/2026